Drug stocks fall as US editorial blasts Merck, FDA
2126
Shares of large US and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of US regulators in monitoring drug safety.
406135
US stock futures pointed to a slightly lower open on Tuesday as investors take a step back after last week&#39;s three-day rally, with shares of drug maker Merck &amp; Co.
537750
US blue chips fell on Thursday after drug company Merck &amp; Co.(MRK.N: Quote, Profile, Research) said it was withdrawing its key arthritis drug Vioxx, while relentless oil prices floated back to $50 a barrel.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
704632
NEW YORK, Sept. 30 -- Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck said it would be forced to remove its best-selling Vioxx arthritis drug from the market. Merck's unexpected bad news left blue chips with a loss for the day, while high-tech stocks got a lift from bargain hunters.
560123
US stocks fell on Friday dragged down by a string of negative reports from drug makers, with Pfizer Inc. (PFE.N: Quote, Profile, Research) , AstraZeneca Plc.
264090
NEW YORK - As Wall Street sifts through more than 300 third-quarter earnings reports this week, technology and pharmaceutical stocks will be getting some of the closest scrutiny.    The focus on drug companies results from a recent spate of bad news about Merck & Co...
122550
The Dow Jones Industrial Average dropped after Merck &amp; Co. withdrew the Vioxx painkiller and retracted its third-quarter profit forecast.
612768
WASHINGTON : Drugs giant Merck and Co.&#39;s shares slumped after the firm revealed civil and criminal investigations into the sale of its pain drug Vioxx.
473820
As far as stock hits go, this ranks up there as one of the worst. Merck &amp; Co. lost more than $26.6 billion in value yesterday - yes, that&#39;s billion with ab - after the pharmaceutical giant
675217
U.S. blue chips fell on Thursday after  drug company Merck & Co.MRK.N said it was withdrawing its key  arthritis drug Vioxx, while relentless oil prices floated back  to $50 a barrel.
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
685306
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , reeling from the recent withdrawal of its Vioxx arthritis drug, on Wednesday said 2005 earnings will decline to
195535
Merck & Co. MRK.N and two other U.S.  drugmakers posted weak third-quarter results on Thursday, hurt  by intensifying competition and the loss of sales from drugs  found to be potentially dangerous.
318860
NEW YORK (CBS.MW) -- Merck (MRK) shares dipped almost 2 percent to $45.16, making it the biggest decliner in the Dow. The selling is related to just surfacing concerns about the safety of its Vioxx arthritis COX-2 inhibitor drug.
288701
Shares of Merck plunged nearly 27 percent yesterday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.